Filippopoulou, F.; Habeos, G.I.; Rinotas, V.; Sophocleous, A.; Sykiotis, G.P.; Douni, E.; Chartoumpekis, D.V.
Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2. Antioxidants 2022, 11, 4.
https://doi.org/10.3390/antiox11010004
AMA Style
Filippopoulou F, Habeos GI, Rinotas V, Sophocleous A, Sykiotis GP, Douni E, Chartoumpekis DV.
Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2. Antioxidants. 2022; 11(1):4.
https://doi.org/10.3390/antiox11010004
Chicago/Turabian Style
Filippopoulou, Fotini, George I. Habeos, Vagelis Rinotas, Antonia Sophocleous, Gerasimos P. Sykiotis, Eleni Douni, and Dionysios V. Chartoumpekis.
2022. "Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2" Antioxidants 11, no. 1: 4.
https://doi.org/10.3390/antiox11010004
APA Style
Filippopoulou, F., Habeos, G. I., Rinotas, V., Sophocleous, A., Sykiotis, G. P., Douni, E., & Chartoumpekis, D. V.
(2022). Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2. Antioxidants, 11(1), 4.
https://doi.org/10.3390/antiox11010004
